Qynapse - The future of neuroimaging is here
  • WHY QYNAPSE
  • I AM
    • Patient or Caregiver
    • Healthcare Provider
    • Pharma
    • Payer
  • PRODUCTS
    • QyScore®
    • QyPredict®
  • COMPANY
    • Team
    • Careers
  • NEWS
    • News & Press Releases
    • Publications
  • CONTACT
Select Page
Qynapse to present clinical results of QyScore® for Alzheimer’s Disease and Multiple Sclerosis at the 7th Congress of the European Academy of Neurology

Qynapse to present clinical results of QyScore® for Alzheimer’s Disease and Multiple Sclerosis at the 7th Congress of the European Academy of Neurology

by Administrators Qynapse | Jun 15, 2021 | News

BOSTON, MA, May 30, 2021 /PRNewswire/ – QYNAPSE Inc., a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, today announced it will present clinical data on QyScore® for Alzheimer’s disease and multiple sclerosis...
Qynapse reaffirms its commitment to research in Multiple Sclerosis and is pleased to announce new projects to advance research and clinical care for MS patients

Qynapse reaffirms its commitment to research in Multiple Sclerosis and is pleased to announce new projects to advance research and clinical care for MS patients

by Administrators Qynapse | May 30, 2021 | News

BOSTON, MA, May 30, 2021 – QYNAPSE Inc., an AI neuroimaging medical technology company, joins the global multiple sclerosis (MS) community in recognition of World MS Day to raise awareness for everyone affected by MS. Emphasizing the World MS Day 2021 theme, MS...
QYNAPSE to Present Latest Advances in its Solutions, Medical Device Software at Sachs 4th Annual Neuroscience Innovation Forum on April 28-30

QYNAPSE to Present Latest Advances in its Solutions, Medical Device Software at Sachs 4th Annual Neuroscience Innovation Forum on April 28-30

by Administrators Qynapse | Apr 26, 2021 | News

BOSTON, MA, April 26, 2021 – QYNAPSE Inc., a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, is pleased to participate in the Sachs 4th Annual Neuroscience Innovation Forum (#Sachs_NIF) on April 28-30, 2021,...
Qynapse joins Decentralized Trials & Research Alliance (DTRA) to democratize and accelerate clinical trials, drastically increase access for all patient populations

Qynapse joins Decentralized Trials & Research Alliance (DTRA) to democratize and accelerate clinical trials, drastically increase access for all patient populations

by Administrators Qynapse | Dec 30, 2020 | News

New Global Industry Coalition That Aims to Dramatically Increase Access for All Patients Populations in Clinical Trials and Research Paris, France and Boston, MA, December 30, 2020 –  QYNAPSE Inc. joins a historic alliance of fifty life sciences and healthcare...
QYNAPSE to sponsor and exhibit at the 106th RSNA Annual Meeting and present its latest AI-neuroimaging advancements, transforming care for patients with brain disorders

QYNAPSE to sponsor and exhibit at the 106th RSNA Annual Meeting and present its latest AI-neuroimaging advancements, transforming care for patients with brain disorders

by Administrators Qynapse | Nov 24, 2020 | News

Paris, FRANCE and Boston, MA, November 24, 2020 / PRNewswire / – QYNAPSE Inc. a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, is pleased to sponsor the 106th Radiology Society of North America (RSNA) Annual...
QYNAPSE appoints Matt Ullum, CPA, MB, as Chief Commercial Officer to drive and accelerate the global growth of the company and its solutions

QYNAPSE appoints Matt Ullum, CPA, MB, as Chief Commercial Officer to drive and accelerate the global growth of the company and its solutions

by Administrators Qynapse | Nov 12, 2020 | News

Paris, France and Boston, MA, November 12th, 2020 – QYNAPSE SAS, a medical technology company commercializing the most advanced neuroimaging AI platform, appoints Matt Ullum, CPA, MBA as Chief Commercial Officer. In his new role, Matt assumes overall responsibility...
« Older Entries
Next Entries »

Careers

Qynapse Office Locations

Expanding Global Presence

Healthcare, Clinical Trial and Research Footprint

QYNAPSE (PARIS)
2-10 rue d’Oradour-sur-Glane
75015 Paris – France

QYNAPSE (BOSTON)
50 Milk St
Boston, MA, 02119 – USA

QYNAPSE (MONTREAL)
7240 Waverly St, Montreal,
Quebec H2R 2Y8 – Canada

contact@qynapse.com

  • Follow
  • Follow

Qynapse is ISO 13485, ISO/IEC27001 and HDS Certified, HIPAA Compliant, GDPR Compliant, and 21 C.F.R. Part 11 Compliant | QyScore® is FDA-Cleared, CE-Marked (CE2797) | Privacy Policy | ©2024 QYNAPSE ALL RIGHTS RESERVED. Last update: Jan 30. 2023

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT